Literature DB >> 28438885

Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative Resection.

Yi-Peng Fu1, Yong Yi1, Jin-Long Huang1, Chu-Yu Jing1, Jian Sun1, Xiao-Chun Ni1, Zhu-Feng Lu1, Ya Cao2, Jian Zhou1, Jia Fan1, Shuang-Jian Qiu3,4.   

Abstract

BACKGROUND: The prognosis of patients with hepatocellular carcinoma (HCC) without portal vein tumor thrombosis (PVTT) after curative resection is at variance. We identified the risk factors of poor postoperative prognosis and consequently developed prognostic nomograms generating individual risk of death and recurrence for this subgroup of patients with HCC.
METHODS: The risk factors were identified and nomograms were developed based on a retrospective study of 734 patients in the primary cohort who underwent curative resection for HCC from 2010 to 2012. The predictive accuracy and discriminative ability of the nomograms were determined by concordance index (C-index) and calibration curve and compared with traditional staging systems of HCC. The results were validated in an independent cohort of 349 patients operated at the same institution in 2007.
RESULTS: All of the independent factors for survival in multivariate analysis in the primary cohort were selected into the nomograms. The calibration curve for probability of survival showed good agreement between prediction by nomograms and actual observation. The C-indices of the nomograms for predicting overall survival and recurrence-free survival were 0.755 (95% confidence interval [CI], 0.752-0.758) and 0.665 (95% CI, 0.662-0.668), respectively, which were statistically higher than the C-indices of other HCC prognostic models. The results were further confirmed in the validation cohort.
CONCLUSION: The proposed nomograms resulted in more accurate prognostic prediction for patients with HCC without PVTT after curative resection. The Oncologist 2017;22:561-569 IMPLICATIONS FOR PRACTICE: Hepatocellular carcinoma (HCC) poses a great therapeutic challenge due to the poor prognosis in patients underwent surgical resection. The portal vein tumor thrombosis (PVTT) as a robust risk factor for survival has been routinely integrated to staging systems. Nonetheless, the prognosis stratification for patients without PVTT was neglected to some extent. Herein, independent risk factors of OS and RFS in HCC patients without PVTT were reconfirmed. A predictive nomogram was constructed on these risk factors and was demonstrated to be a more accurate predictive model in HCC patients without PVTT, compared with the traditional staging systems. © AlphaMed Press 2017.

Entities:  

Keywords:  Hepatocellular carcinoma; Nomogram; Portal vein tumor thrombosis; Prognosis; Resection

Mesh:

Year:  2017        PMID: 28438885      PMCID: PMC5423510          DOI: 10.1634/theoncologist.2016-0231

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  39 in total

Review 1.  Hepatocellular carcinoma--epidemiological trends and risk factors.

Authors:  Kerstin Schütte; Jan Bornschein; Peter Malfertheiner
Journal:  Dig Dis       Date:  2009-06-22       Impact factor: 2.404

2.  Transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a prospective comparative study.

Authors:  Jun Luo; Rong-Ping Guo; Eric C H Lai; Yao-Jun Zhang; Wan Yee Lau; Min-Shan Chen; Ming Shi
Journal:  Ann Surg Oncol       Date:  2010-09-14       Impact factor: 5.344

3.  Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score.

Authors:  Masatoshi Kudo; Hobyung Chung; Seiji Haji; Yukio Osaki; Hiroko Oka; Toshihito Seki; Hiroshi Kasugai; Yo Sasaki; Takashi Matsunaga
Journal:  Hepatology       Date:  2004-12       Impact factor: 17.425

4.  Decision curve analysis: a novel method for evaluating prediction models.

Authors:  Andrew J Vickers; Elena B Elkin
Journal:  Med Decis Making       Date:  2006 Nov-Dec       Impact factor: 2.583

5.  Prognosis of hepatocellular carcinoma: the BCLC staging classification.

Authors:  J M Llovet; C Brú; J Bruix
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

6.  Characterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinoma.

Authors:  T Wang; H S Hu; Y X Feng; J Shi; N Li; W X Guo; J Xue; D Xie; S R Liu; M C Wu; S Q Cheng
Journal:  Br J Cancer       Date:  2010-05-11       Impact factor: 7.640

7.  A novel prognostic nomogram is more accurate than conventional staging systems for predicting survival after resection of hepatocellular carcinoma.

Authors:  Clifford S Cho; Mithat Gonen; Jinru Shia; Michael W Kattan; David S Klimstra; William R Jarnagin; Michael I D'Angelica; Leslie H Blumgart; Ronald P DeMatteo
Journal:  J Am Coll Surg       Date:  2007-10-29       Impact factor: 6.113

Review 8.  Gamma-glutamyl transpeptidase: redox regulation and drug resistance.

Authors:  Marie H Hanigan
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

9.  A nomogram predicting pulmonary metastasis of hepatocellular carcinoma following partial hepatectomy.

Authors:  J Li; Y Liu; Z Yan; X Wan; Y Xia; K Wang; J Liu; W Y Lau; M Wu; F Shen
Journal:  Br J Cancer       Date:  2014-01-30       Impact factor: 7.640

10.  Overexpression of interleukin-35 associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection.

Authors:  Yi-Peng Fu; Yong Yi; Xiao-Yan Cai; Jian Sun; Xiao-Chun Ni; Hong-Wei He; Jia-Xing Wang; Zhu-Feng Lu; Jin-Long Huang; Ya Cao; Jian Zhou; Jia Fan; Shuang-Jian Qiu
Journal:  Br J Cancer       Date:  2016-03-22       Impact factor: 7.640

View more
  22 in total

1.  Controlling nutritional status (CONUT) score-based nomogram to predict overall survival of patients with HBV-associated hepatocellular carcinoma after curative hepatectomy.

Authors:  Z-X Lin; D-Y Ruan; C-C Jia; T-T Wang; J-T Cheng; H-Q Huang; X-Y Wu
Journal:  Clin Transl Oncol       Date:  2019-06-14       Impact factor: 3.405

2.  Prognostic Nomograms for Patients with Hepatocellular Carcinoma After Curative Hepatectomy, with a Focus on Recurrence Timing and Post-Recurrence Management.

Authors:  Wei Xu; Fei Liu; Xianbo Shen; Ruineng Li
Journal:  J Hepatocell Carcinoma       Date:  2020-10-27

3.  Preoperative and postoperative nomograms for predicting early recurrence of hepatocellular carcinoma without macrovascular invasion after curative resection.

Authors:  Yanfang Zhang; Xuezhong Lei; Liangliang Xu; Xiaoju Lv; Mingqing Xu; Hong Tang
Journal:  BMC Surg       Date:  2022-06-17       Impact factor: 2.030

4.  A radiomics nomogram for preoperative prediction of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma.

Authors:  Jie Peng; Jing Zhang; Qifan Zhang; Yikai Xu; Jie Zhou; Li Liu
Journal:  Diagn Interv Radiol       Date:  2018 May-Jun       Impact factor: 2.630

5.  Novel Models Predict Postsurgical Recurrence and Overall Survival for Patients with Hepatitis B Virus-Related Solitary Hepatocellular Carcinoma ≤10 cm and Without Portal Venous Tumor Thrombus.

Authors:  Xiao-Hui Wang; Bing Liao; Wen-Jie Hu; Cai-Xue Tu; Cai-Ling Xiang; Sheng-Hua Hao; Xian-Hai Mao; Xiao-Ming Qiu; Xiao-Jun Yang; Xiao Yue; Ming Kuang; Bao-Gang Peng; Shao-Qiang Li
Journal:  Oncologist       Date:  2020-08-06       Impact factor: 5.837

6.  The clinical significance of microRNA-122 in predicting the prognosis of patients with hepatocellular carcinoma: A meta-analysis validated by the Cancer Genome Atlas dataset.

Authors:  Yanfang Zhang; Yongguo Li; Wenhui Jiang; Qian Li; Yinghua Lan
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

7.  High expression of Oct4 and Nanog predict poor prognosis in intrahepatic cholangiocarcinoma patients after curative resection.

Authors:  Mei-Xia Zhang; Wei Gan; Chu-Yu Jing; Su-Su Zheng; Yong Yi; Juan Zhang; Xin Xu; Jia-Jia Lin; Bo-Heng Zhang; Shuang-Jian Qiu
Journal:  J Cancer       Date:  2019-01-30       Impact factor: 4.207

8.  A nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomy.

Authors:  Yang-Xun Pan; Jian-Cong Chen; Ai-Ping Fang; Xiao-Hui Wang; Jin-Bin Chen; Jun-Cheng Wang; Wei He; Yi-Zhen Fu; Li Xu; Min-Shan Chen; Yao-Jun Zhang; Qi-Jiong Li; Zhong-Guo Zhou
Journal:  Cancer Commun (Lond)       Date:  2019-10-11

9.  Prognostic nomogram for hepatocellular carcinoma with radiofrequency ablation: a retrospective cohort study.

Authors:  Zhenhua Lu; Zhen Sun; Chengyu Liu; Xiaolei Shi; Rui Li; Weiwei Shao; Yangyang Zheng; Yao Li; Jinghai Song
Journal:  BMC Cancer       Date:  2021-06-29       Impact factor: 4.430

10.  Association between Recipient IL-15 Genetic Variant and the Prognosis of HBV-Related Hepatocellular Carcinoma after Liver Transplantation.

Authors:  Tao Zhang; Yuan Liu; Xu Peng; Junwei Fan; Zhihai Peng
Journal:  Dis Markers       Date:  2017-10-15       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.